1 | Post Covid-19 symptoms among Covid-19 patients with comorbidities and non-comorbidities in Peninsular Malaysia | 1171 |
2 | Edible bird nest as a potential cognitive enhancer | 1016 |
3 | C-Abl inhibition; a novel therapeutic target for Parkinson’s disease | 974 |
4 | The promise of the Zebrafish model for Parkinson’s disease: today’s science and tomorrow’s treatment | 924 |
5 | Is sugar or fat worse? | 909 |
6 | Neuroprotective effect of edible bird’s nest in chronic cerebral hypoperfusion induced neurodegeneration in rats | 884 |
7 | Tau protein as a biomarker for asphyxia: a possible forensic tool? | 864 |
8 | Burnout in academia the physiological effects of contagion and isolation go beyond fear of contracting the Covid-19 virus | 853 |
9 | Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) | 816 |
10 | Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease | 816 |
11 | Depression following major life transitions in women: a review and theory | 808 |
12 | Pharmacotherapy of alzheimer’s disease: seeking clarity in a time of uncertainty | 806 |
13 | Thyroxine (T4) transfer from blood to cerebrospinal fluid in sheep isolated perfused choroid plexus: role of
multidrug resistance-associated Proteins and Organic anion
Transporting Polypeptides | 795 |
14 | Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model | 785 |
15 | Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases | 766 |
16 | Light-Emitting Diode (LED) therapy attenuates neurotoxicity of methanol-induced memory impairment and apoptosis in the hippocampus | 763 |
17 | siRNA blocking of mammalian target of rapamycin (mTOR) attenuates pathology in annonacin-induced tauopathy in mice | 753 |
18 | Genetic underpinnings in Alzheimer’s disease –
A review | 743 |
19 | Integrated neural technologies: solutions beyond tomorrow | 740 |
20 | Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls | 738 |
21 | Editorial: biomarkers in neurology | 725 |
22 | Interactions between cannabis and schizophrenia
in humans and rodents | 722 |
23 | Oxidative stress status and neuroprotection of tocotrienols in chronic cerebral hypoperfusion-induced neurodegeneration rat animal model | 711 |
24 | Hormones in experimental autoimmune encephalomyelitis (EAE) animal models | 693 |
25 | Atypical antipsychotic lumateperone effects on the adrenal gland with possible beneficial effect of quercetin co-administration | 689 |
26 | FOXRED1 silencing in mice: a possible animal model for leigh syndrome. | 682 |
27 | Elevation of pro‑inflammatory and anti‑inflammatory cytokines in rat serum after acute methamphetamine treatment and traumatic brain injury | 675 |
28 | Animal model for leigh syndrome | 665 |
29 | Neurotoxin‑induced rodent models of Parkinson’s disease: benefits and drawbacks | 648 |
30 | Editorial: contribution of translational animal models to the systems biology of neurodegenerative disorders | 647 |